Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy
Retrieved on:
Tuesday, November 29, 2022
John Hardesky, Chief Commercial Officer of Nanomix, stated, Gepa has significant experience in this increasingly complex and important segment of critical infections, sepsis, and antibiotic stewardship.
Key Points:
- John Hardesky, Chief Commercial Officer of Nanomix, stated, Gepa has significant experience in this increasingly complex and important segment of critical infections, sepsis, and antibiotic stewardship.
- We are excited to support and align with Gepa on an ambitious execution plan to bring our technology to a competitive market like Italy.
- Riccardo Figus, Business Manager of Gepa, commented, The GEPA team is very excited to develop the Italian market for the new eLab, a true Point of Care device.
- The agreement with Nanomix enables us to offer our customers an innovative solution for the fight against sepsis.